Helius Medical Technologies, Inc., a leading medical technology company focused on neurological wellness, has recently announced the pricing for its public offering of common stock. The company has set the price at $1.50 per share, with the total offering expected to raise approximately $6.4 million.
This public offering represents a significant milestone for Helius Medical Technologies, as it will provide the company with additional capital to support its ongoing research and development efforts. The funds raised will be used to further advance the company’s innovative technology platform, which is designed to improve the lives of patients suffering from neurological disorders.
Helius Medical Technologies is known for its groundbreaking PoNS™ device, a non-invasive neuromodulation system that has shown promising results in the treatment of conditions such as traumatic brain injury and multiple sclerosis. The company’s technology works by delivering electrical stimulation to the tongue, which in turn stimulates the brain’s natural ability to rewire and repair itself.
The public offering of common stock is being underwritten by Maxim Group LLC, a leading investment banking firm. The underwriters have also been granted a 45-day option to purchase up to an additional $960,000 worth of shares at the public offering price.
Investors and stakeholders in the medical technology industry are closely watching Helius Medical Technologies as it continues to make strides in the development of its innovative products. The company’s commitment to improving neurological wellness through cutting-edge technology has garnered attention from both the medical community and investors alike.
In conclusion, Helius Medical Technologies’ public offering of common stock represents a significant opportunity for investors to support a company that is at the forefront of innovation in the field of neurological wellness. With the funds raised from this offering, Helius Medical Technologies will be well-positioned to continue its mission of improving the lives of patients suffering from neurological disorders.